Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group Study

B. F. Cole, R. D. Gelber, J. M. Kirkwood, A. Goldhirsch, E. Barylak, E. Borden

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences